TTK Healthcare Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Sep 2025 is 2.56% vs 6.85% in Sep 2024

Standalone Net Profit

YoY Growth in quarter ended Sep 2025 is 18.55% vs 7.43% in Sep 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is -35.24% vs -13.73% in Sep 2024

Interest

YoY Growth in quarter ended Sep 2025 is 13.51% vs 1.37% in Sep 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024

Compare Quarterly Results Of TTK Healthcare With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

203.57

629.92

-426.35

-67.68%

Other Operating Income

0.00

Total Operating income

203.57

629.92

-426.35

-67.68%

Raw Material Cost

48.05

402.85

-354.80

-88.07%

Purchase of Finished goods

48.77

5.83

42.94

736.54%

(Increase) / Decrease In Stocks

1.03

2.46

-1.43

-58.13%

Employee Cost

41.11

65.90

-24.79

-37.62%

Power Cost

0.00

Manufacturing Expenses

0.00

-0.01

0.01

100.00%

Selling and Distribution Expenses

0.00

Other Expenses

59.28

87.47

-28.19

-32.23%

Total Expenditure (Excl Depreciation)

198.24

564.50

-366.26

-64.88%

Operating Profit (PBDIT) excl Other Income

5.33

65.42

-60.09

-91.85%

Other Income

19.01

17.56

1.45

8.26%

Operating Profit (PBDIT)

24.34

82.98

-58.64

-70.67%

Interest

0.84

5.00

-4.16

-83.20%

Exceptional Items

0.00

Gross Profit (PBDT)

23.50

77.98

-54.48

-69.86%

Depreciation

2.21

12.48

-10.27

-82.29%

Profit Before Tax

21.30

65.50

-44.20

-67.48%

Tax

0.91

17.02

-16.11

-94.65%

Provisions and contingencies

0.00

Profit After Tax

20.39

48.48

-28.09

-57.94%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

20.39

48.48

-28.09

-57.94%

Equity Capital

14.13

171.00

-156.87

-91.74%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

14.43

2.84

11.59

408.10%

Diluted Earnings per share

14.43

2.83

11.60

409.89%

Operating Profit Margin (Excl OI)

2.62%

10.39%

0.00

-7.77%

Gross Profit Margin

11.54%

12.38%

0.00

-0.84%

PAT Margin

10.02%

7.70%

0.00

2.32%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 203.57 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -10.10% vs 18.95% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 2.56% vs 6.85% in Sep 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 20.39 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 56.85% vs -19.50% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 18.55% vs 7.43% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 5.33 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 98.88% vs -77.69% in Jun 2025

YoY Growth in quarter ended Sep 2025 is -35.24% vs -13.73% in Sep 2024

Quarterly - Interest

Interest 0.84 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 9.09% vs -14.44% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 13.51% vs 1.37% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 2.62%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024